Octapharma AG, founded in 1983, is a family-owned pharmaceutical company based in Switzerland. It bills itself as "one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines."[citation needed]
Immunotherapy: immunomodulation or immunoglobulin replacement therapy for the treatment of immune-mediated diseases and deficiencies (immune disorders including autoimmune diseases and antibody deficiency) by inducing, enhancing, or suppressing an immune response.
Octapharma was founded in 1983. In the name Octapharma, the “octa” is derived from the Greek word for eight, named after the factor which is deficient in haemophilia A patients. Octapharma's inaugural product was the first Factor VIII concentrate using what was then innovative solvent detergent virus inactivation technology.
The underlying principle of Octapharma's R&D is the development of therapies based on human proteins either purified from human plasma or produced by recombinant technologies applied to human cell lines.
Productsedit
Octapharma medicines treat a broad range of rare and life-threatening congenital and acquired diseases and conditions:
- bleeding disorders (hemophilia A / B and VWD) - over 300 types of primary and secondary immune deficiencies - numerous auto-immune and neurological disorders - acute conditions - critical care issues (including trauma and burn victims) - cancer patients - major surgeries - protection of new-borns in case of Rh negative pregnancies
Productionedit
Octapharma converts source plasma into plasma protein products through fractionation and processing. Each therapy created is controlled, fractionated, purified, virus-inactivated and inspected before being used.
As of December 31, 2022, Octapharma employs around 10,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Hematology, Immunotherapy and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centers across Europe and the US.
octapharma, this, article, rely, excessively, sources, closely, associated, with, subject, potentially, preventing, article, from, being, verifiable, neutral, please, help, improve, replacing, them, with, more, appropriate, citations, reliable, independent, th. This article may rely excessively on sources too closely associated with the subject potentially preventing the article from being verifiable and neutral Please help improve it by replacing them with more appropriate citations to reliable independent third party sources November 2019 Learn how and when to remove this template message Octapharma AG founded in 1983 is a family owned pharmaceutical company based in Switzerland It bills itself as one of the largest human protein manufacturers in the world developing and producing human proteins from human plasma and human cell lines citation needed Octapharma AGCompany typePrivateIndustryPharmaceutical industryFounded1983HeadquartersLachen canton of Schwyz SwitzerlandNumber of locations31Productsoctanate octanine F wilate Nuwiq octagam gammanorm rhesonativ panzyga albunorm octaplas atenativ octaplex octaplasLG fibrygaSee complete products listing RevenueEuro 2 8 billion 2022 1 Number of employees11 573 2022 2 Websitewww octapharma com Contents 1 Therapeutic Areas 2 History 3 Products 4 Production 5 Notes and references 6 See also 7 External linksTherapeutic Areas editPatients in 118 countries are treated with products in the following therapeutic areas Haematology high purity coagulation factor concentrates for patients with bleeding disorders Haemophilia A B and von Willebrand Disease Immunotherapy immunomodulation or immunoglobulin replacement therapy for the treatment of immune mediated diseases and deficiencies immune disorders including autoimmune diseases and antibody deficiency by inducing enhancing or suppressing an immune response Critical Care human plasma and protein products for treating critically ill or injured patients in intensive care and emergency medicine settings 3 History editOctapharma was founded in 1983 In the name Octapharma the octa is derived from the Greek word for eight named after the factor which is deficient in haemophilia A patients Octapharma s inaugural product was the first Factor VIII concentrate using what was then innovative solvent detergent virus inactivation technology The underlying principle of Octapharma s R amp D is the development of therapies based on human proteins either purified from human plasma or produced by recombinant technologies applied to human cell lines Products editOctapharma medicines treat a broad range of rare and life threatening congenital and acquired diseases and conditions bleeding disorders hemophilia A B and VWD over 300 types of primary and secondary immune deficiencies numerous auto immune and neurological disorders acute conditions critical care issues including trauma and burn victims cancer patients major surgeries protection of new borns in case of Rh negative pregnanciesProduction editOctapharma converts source plasma into plasma protein products through fractionation and processing Each therapy created is controlled fractionated purified virus inactivated and inspected before being used As of December 31 2022 Octapharma employs around 10 000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas Hematology Immunotherapy and Critical Care Octapharma has seven R amp D sites and five state of the art manufacturing facilities in Austria France Germany and Sweden and operates more than 190 plasma donation centers across Europe and the US Notes and references edit Annual report 2022 https www octapharma com news press release 2022 octapharma group delivers strong growth in sales and operating income in 2021 About us on https www octapharma com about us who we are Octapharma Website http www octapharma com en patients diseases therapies htmlSee also editList of pharmaceutical companies Pharmaceutical industry in SwitzerlandExternal links edit nbsp Wikimedia Commons has media related to Octapharma Official website Octapharma Plasma Inc Website Portals nbsp Companies nbsp Switzerland Retrieved from https en wikipedia org w index php title Octapharma amp oldid 1172869161, wikipedia, wiki, book, books, library,
